Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BMO Capital Cuts Albertsons Price Target By 7%

BMO Capital analyst Kelly Bania lowered the price target on Albertsons Companies Inc (NYSE:ACI) to $24 from $26 and maintained an Underperform rating…
byShivani Kumaresan
July 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • BMO Capital analyst Kelly Bania lowered the price target on Albertsons Companies Inc (NYSE:ACI) to $24 from $26 and maintained an Underperform rating on the shares.
  • The analyst thinks there is a higher chance that consumer headwinds and signs of trade-down on value could hamper the company’s earnings.
  • The analyst also warned about the impact of a possible wave of wage investments for unionized grocers on Albertsons’ earnings.
  • Price Action: ACI shares are trading lower by 0.26% at $26.35 on the last check Friday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Asia And Europe Markets Dip, Crude And Gold In Green – Global Markets Today While US Was Sleeping

By Akanksha Bakshi
January 16, 7:54 AM
Japan's Nikkei 225 and Australia's S&P/ASX 200 closed lower, while China's markets showed modest gains. In Europe, major indexes like Germany's DAX and France's CAC experienced declines. Commodity updates reveal a mixed scenario with rising crude oil prices and a dip in natural gas and gold values

ADIV

Read More

Acadia Pharmaceuticals Announces Label Update for NUPLAZID; U.S. FDA Revises Boxed Warning To Clarify That Nuplazid Can Be Used To Treat Patients With Parkinson’s Disease-Related Hallucinations And Delusions Who Also Have Dementia

By Benzinga Newsdesk
September 18, 11:20 AM
— U.S. FDA revises Boxed Warning to clarify that NUPLAZID can be used to treat patients with Parkinson's disease-related hallucinations and delusions who also have dementiaSAN DIEGO — September 18, 2023 – Acadia

ACAD